Our findings illustrate the novel capacity of SIRT2 to enhance subcutaneous melanoma progression while raising the vital question of at what point does SIRT2, a tumor suppressor protein that promotes genomic integrity in healthy cells, transition into what can only be described as a tumor promoter. This evidence concerns the gene SIRT2 and melanoma.